Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Crucell and NIAID expand Ebola vaccine agreement to include Marburg and Lassa vaccines

Aug. 13, 2002

Adjuvant QS-21 enhances immunogenicity of malaria peptide vaccine

Aug. 6, 2002

Zonagen receives SBIR grant to study adjuvant system

Aug. 5, 2002

Marketing authorization for Triacelluvax withdrawn in E.U.

Aug. 5, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Plexus Vaccine and GlaxoSmithKline sign vaccine research agreement

July 25, 2002

Enrollment completed in phase II/III trial of ABX-CBL in steroid-resistant GVHD

July 24, 2002

New CB2 agonists and their use in autoimmune diseases, etc.

July 16, 2002

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

July 16, 2002

MedImmune receives FluMist complete response letter

July 15, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...